Docetaxel in very elderly men with metastatic castration-resistant prostate cancer

PURPOSE: To evaluate the use of docetaxel in very elderly men with metastatic castration-resistant prostate cancer (mCRPC) treated in routine clinical care. METHODS: A retrospective case series of men with mCRPC aged ≥80 years and treated with docetaxel between July 2006 and June 2012 at three commu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Hui-Li, Lok, Sheau Wen, Wong, Shirley, Parente, Phillip, Rosenthal, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494632/
https://www.ncbi.nlm.nih.gov/pubmed/26157766
http://dx.doi.org/10.1016/j.prnil.2015.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494632/
https://www.ncbi.nlm.nih.gov/pubmed/26157766
http://dx.doi.org/10.1016/j.prnil.2015.03.003

Ejemplares similares